Skip to main content

Want a detailed portfolio tracker?

Cara Therapeutics (TVRD) P/E (2014 - 2026)

Cara Therapeutics (TVRD) P/E from Jan 31, 2014 to Jul 21, 2026. The TTM Cara Therapeutics (TVRD) P/E is -1.74. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Cara Therapeutics (TVRD)

YearP/EChange
2026-1.74+296.61%
2025-0.44-52.59%
2024-0.92+168.36%
2023-0.34-94.70%
2022-6.50-7.98%
2021-7.06-103.56%
2020198.17-3108.47%
2019-6.59-20.92%
2018-8.33-94.18%
2017-143.07+31.75%
2016-108.59-44.90%
2015-197.07+69.11%
2014-116.53N/A

Comparison Cara Therapeutics (TVRD) P/E with competitors

Cara Therapeutics (TVRD) P/E is -1.74.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.10%
NBYStablecoin Development Corp0.00-100.25%
ENLVEnlivex Ltd0.07-104.30%
FGENFibroGen Inc0.24-113.80%
CHRSCoherus Biosciences Inc0.85-148.79%
FBIOFortress Biotech Inc0.95-154.57%
ORMPOramed Pharmaceuticals Inc1.50-186.42%
AGENAgenus Inc3.01-273.05%
INVAInnoviva Inc3.15-281.35%
VXRTVaxart Inc3.55-304.10%
CRMDCorMedix Inc3.63-308.63%
CVACCureVac N.V.4.45-355.62%
GLPGGalapagos NV4.86-379.38%
SRPTSarepta Therapeutics Inc4.88-380.71%
ABEOAbeona Therapeutics Inc5.39-409.77%
ABUSArbutus Biopharma Corp5.60-421.74%
ZVRAZevra Therapeutics Inc5.89-438.50%
SPROSpero Therapeutics Inc6.23-458.12%
CGENCompugen Ltd6.31-463.04%
RIGLRigel Pharmaceuticals6.87-495.13%
SLXNSilexion Therapeutics Corp7.30-519.51%
OMEROmeros Corporation9.26-632.36%
AUPHAurinia Pharmaceuticals Inc9.58-651.12%
PLXProtalix BioTherapeutics Inc10.89-726.21%
ACADAcadia Pharmaceuticals Inc11.73-774.37%
TBPHTheravance Biopharma Inc12.26-805.05%
ADMAAdma Biologics Inc12.42-814.02%
HRMYHarmony Biosciences Holdings Inc13.82-894.64%
SABSSAB Biotherapeutics Inc14.14-912.81%
NAGENiagen Bioscience Inc14.82-952.01%
INCYIncyte Corp15.82-1009.77%
REGNRegeneron Pharmaceuticals Inc15.86-1011.73%
PBYIPuma Biotechnology Inc17.32-1095.62%
CPRXCatalyst Pharmaceuticals Inc17.44-1102.73%
EXELExelixis Inc17.54-1108.40%
TGTXTG Therapeutics Inc18.97-1190.51%
MDXGMimedx Group Inc20.55-1281.73%
XOMAXOMA Royalty Corp22.87-1415.29%
ARGXArgen X SE24.30-1497.13%
CTMXCytomX Therapeutics Inc24.82-1527.21%
XOMAOXOMA Royalty Corp25.34-1557.32%
HALOHalozyme Therapeutics Inc25.62-1573.36%
XOMAPXOMA Royalty Corp25.67-1576.02%
VRTXVertex Pharmaceuticals Inc27.99-1709.69%
RPRXRoyalty Pharma plc - Class A28.69-1749.52%
SLNOSoleno Therapeutics Inc29.02-1768.37%
ASNDAscendis Pharma A/S30.09-1829.91%
LGNDLigand Pharmaceuticals Inc - Class B37.91-2279.93%
APLSApellis Pharmaceuticals Inc39.02-2343.71%
BMRNBiomarin Pharmaceutical Inc42.21-2527.17%
KRYSKrystal Biotech Inc45.34-2707.24%
ONCBeiGene Ltd69.54-4098.56%
PHARPharming Group N.V.75.03-4413.95%
TECHBio-Techne Corp101.96-5962.58%
VCELVericel Corp109.92-6420.45%
ALNYAlnylam Pharmaceuticals Inc117.96-6882.96%
GMABGenmab140.29-8166.68%
TLXTelix Pharmaceuticals Ltd162.15-9423.75%
CORTCorcept Therapeutics Inc212.86-12339.25%